𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prognostic impact of hematogenous tumor cell dissemination in patients with stage II colorectal cancer

✍ Scribed by Moritz Koch; Peter Kienle; Dorejd Kastrati; Dalibor Antolovic; Jan Schmidt; Christian Herfarth; Magnus von Knebel Doeberitz; Jürgen Weitz

Publisher
John Wiley and Sons
Year
2006
Tongue
French
Weight
240 KB
Volume
118
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Adjuvant chemotherapy is not routinely recommended in patients with colorectal cancer stage UICC II. Some of these patients, however, develop recurrent disease. Therefore, valid prognostic criteria are needed to identify high‐risk patients who might benefit from adjuvant therapy. Disseminated tumor cells, detected in blood and bone marrow, may prove to be a valid marker, however, the prognostic relevance of these cells remains debated. In our study, we examined the prognostic significance of disseminated tumor cells in blood and bone marrow of patients with stage II colorectal cancer. Ninety patients with potentially curative (R0) resection of colorectal cancer stage II were prospectively enrolled into the study. Bone marrow and blood samples were examined for disseminated tumor cells by CK 20 RT‐PCR. Patient, tumor and treatment factors were analyzed as prognostic factors. Multivariate analysis confirmed tumor cell detection in blood (hazard ratio 2.1, p = 0.03) and T‐category (hazard ratio 2.2, p = 0.02) to be independent prognostic factors for relapse‐free survival. Tumor cell detection in postoperative blood samples (hazard ratio 7.7, p < 0.001) and number of removed lymph nodes (hazard ratio 6.4, p < 0.001) were independent prognostic factors for disease‐specific survival. Detection of circulating tumor cells in blood samples of patients with stage II colorectal cancer identifies patients with poor outcome. This finding should be confirmed by further studies and could then be used as a basis for conducting a randomized trial evaluating the effect of adjuvant chemotherapy in stage II patients. © 2006 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Prognostic significance of mesenteric tu
Prognostic significance of mesenteric tumor nodules in patients with stage III colorectal cancer
✍ Dorothy S. Lo; Aaron Pollett; Lillian L. Siu; Steve Gallinger; Ronald L. Burkes 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 1 views

## Abstract ## BACKGROUND. Tumor nodules are occasionally found in adjacent mesentery of colorectal cancer specimens and are felt to reflect a worse prognosis. The clinical significance of mesenteric tumor nodules was investigated. ## METHODS. A review of 786 patients with stage III colorectal c

Detection of disseminated tumor cells in
Detection of disseminated tumor cells in peripheral blood of colorectal cancer patients
✍ Marc G. Denis; Cecile Lipart; Joël LeBorgne; Paul-Antoine LeHur; Jean-Paul Galmi 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 117 KB 👁 2 views

All cancer staging systems seek to identify clinical and pathological features that can predict outcome or guide therapy. In particular, a non-invasive method for the early detection of disseminating disease would be of great interest. We investigated the use of cytokeratin genes expression to detec

Patterns of disease recurrence influence
Patterns of disease recurrence influenced by hematogenous tumor cell dissemination in patients with cervical carcinoma of the uterus
✍ Wolfgang Janni; Florian Hepp; Barbara Strobl; Brigitte Rack; Dorothea Rjosk; Chr 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB

## Abstract ## BACKGROUND The presence of isolated tumor cells (ITC) in the bone marrow at the time of primary diagnosis indicates an increased risk for subsequent development of distant metastases in various solid tumors. This study evaluates the prevalence and prognostic significance of ITC in p